DRKS00028493招募中不适用
Setting the stage for newborn screening and gene therapy: a disease-specific retrospective survey of FHL2 and 3 - FHL2/3 Study
niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz (CCI)im Zentrum für Translationale Zellforschung0 个研究点目标入组 200 人开始时间: 2022年9月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •Genetic diagnosis of FHL2 OR FHL3
- •Initial disease manifestation and diagnosis between 2010 and 2020
排除标准
- •lack of follow-up data (at least alive/dead) 1 year after HSCT or diagnosis
研究者
相似试验
招募中
Unknown
Establishment of expanded newborn screening system in Tokyo metropolitaSpiral Muscular Atrophy, Severe Combinede Immunodeficiency, Pompe Disease, Mucopolysaccharidosis type I &II, Fabry diseaseJPRN-UMIN000048900Department of Pediatrics, The Jikei University School of Medicine4,000
已完成
不适用
Research on newborn screening for treatable neonatal and childhood diseasesprimary immunodeficiency, spinal muscular atrophyJPRN-UMIN000045633Tokyo Medical and Dental University
尚未招募
不适用
Genetic Newborn Screening for Rare Diseases within the Screen4Care Projectgenetic newborn screeningDRKS00033501niversitätsklinikum Freiburg; Klinik für Neuropädiatrie und Muskelerkrankungen20,000
招募中
不适用
establishing newborn screening program for metabolic disorders in Udupi DistrictCTRI/2017/09/009912Vision Group Science and Technology
招募中
不适用
PAN INDIA Genetics Study of MODYCTRI/2019/12/022394Dr V Mohan